Frequently Asked Questions
The COVID-19 outbreak had a significant influence on the healthcare industry. The pandemic negatively impacted the market for treating polycystic ovarian syndrome (PCOS), which had an impact on numerous surgical procedures, including laparoscopic ovarian syndrome.
North America accounted for the highest share in the global polycystic ovary syndrome treatment market.
Surging cases of PCOS and expanding the healthcare industry are the major factors driving the market’s growth.
Insulin Sensitizing Agent segment had a major market revenue share in 2021. Besides, it is also projected to witness the fastest growth.
The Hospital Pharmacies segment had a major share in the global market in 2021 and is projected to continue its dominance over the forecast period.